WCLC 2026: Investigational immunotherapy nearly doubles overall survival compared with docetaxel in advanced squamous NSCLC
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
WCLC 2026: Investigational immunotherapy nearly doubles overall survival compared with docetaxel in advanced squamous NSCLC
WCLC 2026: Early cranial radiotherapy may improve outcomes for patients with EGFR-mutant NSCLC and limited brain metastases
WCLC 2026: Mobile CT lung cancer screening expands access for underserved populations in Brazil
WCLC 2026: Investigator presents final PAPILLON trial results showing long-term survival in a subset of lung cancer
Faecal microbiota transplantation may improve immunotherapy-related colitis
WCLC 2026: Brain MRI surveillance without prophylactic cranial irradiation improves cognitive outcomes in small cell lung cancer
WCLC 2026: Sacituzumab govitecan plus pembrolizumab does not meet primary endpoints in first-line PD-L1-high metastatic NSCLC
WCLC 2026: Late-breaking HARMONi-2 analysis shows ivonescimab significantly improves overall survival versus pembrolizumab in PD-L1-Positive Advanced NSCLC
WCLC 2026: Pumitamig plus elfetabart drozuntecan shows encouraging early activity in small cell lung cancer
WCLC 2026: Early cranial radiotherapy may improve outcomes for patients with EGFR-mutant NSCLC and limited brain metastases
WCLC 2026: Brain MRI surveillance without prophylactic cranial irradiation improves cognitive outcomes in small cell lung cancer
WCLC 2026: Mobile CT lung cancer screening expands access for underserved populations in Brazil